News from kalobios pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:KBIO)

Feb 02, 2016, 11:41 ET

KaloBios Pharmaceuticals, Inc. Releases Statement Regarding U.S. Trustee Motion

KaloBios Pharmaceuticals, Inc. (the "Company") today released a statement in response to the motion filed on February 1, 2016 by the U.S. Trustee...

Jan 12, 2016, 16:15 ET

KaloBios Pharmaceuticals, Inc. Withdraws Appeal on Nasdaq Delisting

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) (the "Company"), today announced that it has decided to withdraw its appeal of the...

Jan 11, 2016, 11:46 ET

KaloBios Pharmaceuticals, Inc. Announces Board Changes and New Appointments

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO)(the "Company"), today announced that on January 7, 2016, Ronald Barliant and Dr. Cameron Durrant...

Dec 31, 2015, 10:57 ET

KaloBios Pharmaceuticals, Inc. Notified by Nasdaq Stock Market of Additional Bases for Delisting

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO)(the "Company"), today announced that on December 30, 2015, it received a letter from The NASDAQ Stock...

Dec 30, 2015, 11:20 ET

KaloBios Pharmaceuticals, Inc. Files For Chapter 11 Bankruptcy Protection

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO)(the "Company"), today announced that on December 29, 2015, it filed a voluntary petition for...

Dec 29, 2015, 12:29 ET

KaloBios Pharmaceuticals, Inc. Announces Submission of Request for Appeal of Nasdaq Delisting

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) (the "Company") today announced that on December 28, 2015, the Company submitted a request to...

Dec 23, 2015, 16:30 ET

KaloBios Pharmaceuticals, Inc. Notified by Nasdaq Stock Market of Delisting

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) (the "Company"), today announced that on December 18, 2015, it received a letter from the Nasdaq...

Dec 21, 2015, 09:33 ET

KaloBios Pharmaceuticals, Inc. Announces Management Changes

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), today announced that on December 17, 2015, Martin Shkreli was terminated as Chief Executive...

Dec 03, 2015, 17:16 ET
KaloBios logo.

KaloBios Pharmaceuticals, Inc. Raises $8.2 Million in Private Placement

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), today announced it has entered definitive agreements with institutional and accredited...

Dec 03, 2015, 17:04 ET
KaloBios logo.

KaloBios Announces Agreement to Acquire Benznidazole Program for the Treatment of Chagas Disease

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), today announced that it has signed an agreement to acquire a benznidazole program for the...

Dec 03, 2015, 08:30 ET
KaloBios logo.

KaloBios Announces Management Additions

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), today announced that Patrick Crutcher has been appointed Head of Business Development, Chris Thorn...

Nov 19, 2015, 23:33 ET
KaloBios logo.

KaloBios Pharmaceuticals, Inc. Appoints Martin Shkreli CEO and Announces New Financing

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), today announced that an investor group led by Martin Shkreli, the Founder and Chief Executive...

Nov 18, 2015, 19:27 ET
KaloBios logo.

KaloBios Confirms Communications with Majority Shareholder Group

KaloBios Pharmaceuticals, Inc. (Nasdaq:KBIO) today announced that it has been informed that an investor group comprised of Martin Shkreli and...

Nov 13, 2015, 16:40 ET
KaloBios logo.

KaloBios to Wind Down Operations

 KaloBios Pharmaceuticals, Inc. (Nasdaq:KBIO) today announced that it will wind down its operations and that it has engaged the Brenner Group...

Nov 05, 2015, 17:30 ET
KaloBios logo.

KaloBios to Reduce Workforce, Explore Strategic Alternatives

 KaloBios Pharmaceuticals, Inc. (Nasdaq:KBIO) today announced that it will reduce its workforce as part of a plan to reduce operating costs....

Oct 15, 2015, 13:30 ET
KaloBios logo.

KaloBios to Present at 14th Annual BIO Investor Forum

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that it will present at the 14th Annual BIO Investor Forum in San Francisco,...

Aug 10, 2015, 08:01 ET
KaloBios logo

KaloBios Reports Second Quarter Financial Results and Provides Clinical Update

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), a monoclonal antibody company focused on oncology, today announced its financial results for...

Jul 29, 2015, 13:00 ET
KaloBios logo

KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), a monoclonal antibody company focused on developing innovative therapies to benefit patients...

Jul 29, 2015, 10:16 ET
KaloBios logo.

KaloBios Regains Compliance with NASDAQ Minimum Bid Price Requirement

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), a monoclonal antibody company focused on developing innovative therapies to benefit patients with...

Jul 13, 2015, 08:01 ET
KaloBios logo.

KaloBios Announces Shareholders and Board of Directors Approval of Reverse Stock Split

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), a monoclonal antibody company focused on developing innovative therapies to benefit patients...